SNC Therapeutics, Inc. — Form D
SNC Therapeutics, Inc. of Evanston, IL, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-08. The offering totals $5.0M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-08
- Form: D
- Accession: 0001966964-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $250K
- Remaining: $4.8M
- Minimum investment: $250K
- Investors: 1
- Date of first sale: 2023-02-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-475270
Issuer
- Name: SNC Therapeutics, Inc.
- CIK: 0001966964
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1801 Maple Avenue, Evanston, IL, 60201
- Phone: (904) 707-9016
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Margarita A Chavez | Director | Evanston, IL |
| Evan A Scott | Director | Evanston, IL |
| Jeffrey A Hubbell | Executive Officer | Evanston, IL |
| Evan A Scott | Executive Officer | Evanston, IL |
More